The global nutrigenomics market size reached USD 1,340 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,171 Million by 2033, exhibiting a growth rate (CAGR) of 10% during 2025-2033. The growing awareness about gene-diet interactions and their impact on overall health is stimulating the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 1,340 Million |
Market Forecast in 2033
|
USD 3,171 Million |
Market Growth Rate 2025-2033 | 10% |
Growing Demand for Personalized Nutrition Solutions
Nutrigenomics is increasingly used to create personalized diets based on an individual's genetic makeup, helping to optimize health and prevent disease. This approach shifts away from generalized nutrition plans, offering tailored solutions that align with unique biological needs for better outcomes. For instance, in August 2024, Avesthagen and Apollo AyurVAID partnered to launch "AvestaAyurVAID," integrating Ayurveda with nutrigenomics to create personalized medical foods and dietary supplements. This collaboration aims to address specific nutritional needs for chronic diseases, promoting scientifically validated, plant-based solutions for proactive health management. According to the nutrigenomics market forecast report, this is acting as a significant growth-inducing factor.
Integration of AI and Genetic Data
The combination of AI and genetic analysis allows for more accurate and actionable nutritional recommendations. AI helps in understanding complex gene-diet interactions by analyzing large datasets, thereby enabling more precise interventions for improving health through personalized dietary changes. For instance, in July 2024, Vieroots Wellness Solutions introduced the EPLIMO program, combining AI and genetic science to offer personalized wellness plans based on nutrigenomics. This initiative uses genetic data to suggest diet, supplements, and lifestyle changes, aiming to reduce disease risks and promote optimal health. This is escalating the nutrigenomics market demand.
Increased Focus on Chronic Disease Management
Nutrigenomics plays a crucial role in managing chronic conditions by offering targeted nutrition plans that can mitigate disease risks. Moreover, personalized diets are becoming a key tool in addressing issues like diabetes, cardiovascular disease, and obesity, helping individuals manage these conditions more effectively through tailored nutritional strategies. For instance, in August 2024, the GENEY program was launched to promote precision nutrition among youth, focusing on integrating genetic insights with dietary education. The initiative aims to address obesity and non-communicable diseases by fostering awareness of nutrigenomics in schools and encouraging healthier lifestyle choices among students.
IMARC Group provides an analysis of the key trends in each segment of the market, along with the nutrigenomics market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, sample type, application, and end user.
Breakup by Product:
The report has provided a detailed breakup and analysis of the market based on the product. This includes reagents and kits and services.
Nutrigenomics reagents and kits and services support genetic testing and analysis for personalized nutrition. These products help identify gene-diet interactions, enabling tailored dietary recommendations. In addition, services often include genetic profiling, data interpretation, and personalized wellness plans to optimize health through nutrition based on individual genetic markers. This is expanding the nutrigenomics market outlook.
Breakup by Sample Type:
The report has provided a detailed breakup and analysis of the market based on the sample type. This includes saliva, buccal swab, blood, and others.
Nutrigenomics uses various sample types, such as saliva, buccal swabs, and blood, to analyze genetic data. Saliva and buccal swabs are non-invasive methods, while blood provides more detailed genomic information. These samples help create personalized nutrition plans based on genetic profiles to optimize health outcomes. This is escalating the nutrigenomics market share.
Breakup by Application:
The report has provided a detailed breakup and analysis of the market based on the application. This includes cardiovascular diseases, obesity, cancer research, and others.
Nutrigenomics studies the relationship between genetics and diet, focusing on how individual genetic variations influence the risk of cardiovascular diseases, obesity, and cancer, thereby enabling personalized nutritional interventions for improved health outcomes.
Breakup by End User:
The report has provided a detailed breakup and analysis of the market based on the end user. This includes dieticians, sport clinics, corporate programs, and others.
As per the nutrigenomics market outlook report, dieticians play a vital role in tailoring dietary plans based on genetic profiles, enhancing health outcomes. In contrast, sport clinics leverage this approach to optimize athletic performance, while corporate programs focus on personalized nutrition for employee wellness and productivity.
Breakup by Region:
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
As per the nutrigenomics market analysis report, in Asia Pacific, the market is growing rapidly due to increasing health awareness and rising disposable incomes. In contrast, Europe emphasizes personalized nutrition regulations and research initiatives, while North America leads in technological advancements and consumer adoption. Apart from this, Latin America shows potential with growing interest in wellness, and the Middle East and Africa are expanding, driven by rising obesity rates and healthcare investments.
The nutrigenomics market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered | Reagents and Kits, Services |
Sample Types Covered | Saliva, Buccal Swab, Blood, Others |
Applications Covered | Cardiovascular Diseases, Obesity, Cancer Research, Others |
End Users Covered | Dieticians, Sport Clinics, Corporate Programs, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc., Xcode Life, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: